Tag: Liver Disease: Misc.
Referral to Hepatology Low With Excessive Alcohol Use, High FIB-4
Referral lower for patients with mental health admissions or mental health diagnoses and with increasing age
GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, Diabetes
Compared with DPP-4i use, GLP-1 RA use also associated with lower risk for composite of cirrhosis complications, mortality
Liver Grafts Feasible From Hep C-Positive Donors After Circulatory Death
One-year patient and graft survival comparable to donation after brain death, with or without HCV infection
People With Chronic Liver Disease Face More Barriers to Health Care
Findings tied to higher prevalence of socioeconomic vulnerabilities compared with those with chronic obstructive pulmonary disease or cardiovascular disease
New Definition of Steatotic Liver Disease Improves Prediction of Kidney Disease
Classification of SLD based on the presence of metabolic dysfunction and alcohol consumption
Study Reveals MASLD, MetALD Responsible for One-Third of ICU Cirrhosis Cases
Metabolic dysfunction-associated steatotic liver disease has similar outcomes to alcohol-related liver disease
Childhood Physical Activity Levels Tied to Risk for Liver Disease in Young Adults
Increasing physical activity in childhood tied to reduced risk for severe liver steatosis and liver cirrhosis
Survodutide Tied to Significant Improvement in Fatty Liver Disease
Benefits seen without worsening of fibrosis over 48 weeks
Tirzepatide Beneficial for Resolution of MASH in Patients With MASH, Fibrosis
More patients met criteria for resolution of MASH without worsening of fibrosis with 52 weeks of tirzepatide
Semaglutide Alleviates Metabolic-Linked Liver Disease in People With HIV
29 percent of participants had complete resolution of metabolic-associated steatotic liver disease
